Replimune Group, Inc. (REPL)

CIK 1737953 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Replimune Group, Inc..

Recent SEC filings

FiledFormAccession number
Aug 24, 202640001104659-26-100437
Aug 19, 202640001104659-26-098868
Aug 14, 2026S-3ASR0001104659-26-097309
Aug 14, 202610-Q0001628280-26-057099
Aug 14, 2026SCHEDULE 13G/A0001104659-26-097040
Aug 14, 20268-K0001104659-26-096483
Aug 12, 202640001104659-26-095008
Aug 12, 202640001104659-26-095012
Aug 12, 202640001104659-26-095003
Aug 12, 202640001104659-26-095006
Aug 11, 2026SCHEDULE 13D/A0001104659-26-094196
Aug 11, 20268-K/A0001104659-26-093512
Aug 11, 202640001193125-26-345144
Aug 10, 20268-K0001104659-26-093042
Aug 10, 2026SCHEDULE 13G0000886982-26-000320
Aug 10, 2026424B50001104659-26-093040
Aug 7, 20268-K0001104659-26-092246
Aug 7, 2026SCHEDULE 13G0000093751-26-000533
Aug 6, 2026SCHEDULE 13G/A0000919574-26-004843
Jul 31, 20268-K0001104659-26-088857
Jul 30, 20268-K0001104659-26-088481
Jul 29, 2026DEFA14A0001104659-26-087651
Jul 29, 2026EFFECT9999999995-26-002486
Jul 29, 2026DEF 14A0001104659-26-087650
Jul 29, 2026ARS0001104659-26-087654